Details for New Drug Application (NDA): 204618
✉ Email this page to a colleague
The generic ingredient in ETOMIDATE is etomidate. There are six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the etomidate profile page.
Summary for 204618
Tradename: | ETOMIDATE |
Applicant: | Avet Lifesciences |
Ingredient: | etomidate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 204618
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 2MG/ML | ||||
Approval Date: | Aug 13, 2014 | TE: | RLD: | No |
Complete Access Available with Subscription